In a remarkable turnaround, a panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig's disease. Patients and their families have rallied behind Amylyx's drug, urging approval.
A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig’s disease, a remarkable turnaround for the much-debated medication that was previously rejected by the same group.
A closely watched experimental drug for Lou Gehrig’s disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to.